David M. Stark - Mar 3, 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Exec. VP Chief Legal Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for David M. Stark
Stock symbol
TEVA
Transactions as of
Mar 3, 2023
Transactions value $
$0
Form type
4
Date filed
3/7/2023, 03:14 PM
Previous filing
Mar 2, 2023
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +13.9K +468.36% 16.9K Mar 4, 2023 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +31.8K +188.32% 48.7K Mar 4, 2023 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +20.2K +41.44% 68.9K Mar 5, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +94.6K $0.00 94.6K Mar 3, 2023 Ordinary Shares 94.6K Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -13.9K -100% $0.00* 0 Mar 4, 2023 Ordinary Shares 13.9K Direct F1, F2, F4
transaction TEVA Restricted Share Units Options Exercise $0 -31.8K -25% $0.00 95.5K Mar 4, 2023 Ordinary Shares 31.8K Direct F1, F2, F5
transaction TEVA Restricted Share Units Options Exercise $0 -20.2K -33.33% $0.00 40.4K Mar 5, 2023 Ordinary Shares 20.2K Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027.
F4 Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
F5 Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026.
F6 Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025.